Mathematical modeling of immune response in breast cancer: the effect of tBregs and rituximab
Sep 6, 2022·
·
1 min read
Vasilis Tsilidis
Abstract
We present our discoveries regarding the interactions of breast cancer and the immune system. In particular, we investigate the complex way tBregs, a newly discovered subgroup of B cells, interacts with the immune system. Additionally, we model the way NK cells lyse breast cancer cells. Finally, we test rituximab as a potential breast cancer cure.
Date
Sep 6, 2022 11:00 AM
Event
Location
Foundation for Research and Technology Hellas (FORTH)
100 Nikolaou Plastira str., Heraklion, Crete 94305
Click on the PDF button above to view the slides.
